TG Therapeutics Inc at Ladenburg Thalmann Virtual Healthcare Conference Transcript
Good afternoon. It's my pleasure to introduce our next presenting company, TG Therapeutics. Presenting for the Company today is CEO Mike Weiss. Mike, thanks for joining us at the conference. And we are going to have this as a fireside chat, so it should be fun.
I guess for the people who are not familiar with TG, can you give us kind of a brief background on the Company and your overall vision for the Company as well to start with?
Yes, sure, absolutely. Thanks for having us, Matt. Really appreciate it, and great to see you. So TG, we founded TG in 2012. The mission has been and continues to be about providing the best treatment options possible for patients with B cell diseases. So that includes cancers like chronic lymphocytic leukemia, marginal zone lymphoma and follicular lymphoma. And on the autoimmune side, B cell diseases include MS, where we have a large program, and other areas, including lupus, RA could be
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |